UPC APP 60159/2024
Nov 8, 2024·EP3646825 · A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER
- Case details
- StatusCase ClosedActionGenericCategoryCosts assessments
- Parties
- Claimants
- Meril Life Sciences Pvt Ltd.Operating co.
Representatives- Andreas Johannes Nikolaus von Falck-Hogan Lovells International LLP
- Roman Würtenberger-Hogan Lovells International LLP
- Lukas Wollenschlaeger-Hogan Lovells International LLP
- Beatrice Wilden-Hogan Lovells International LLP
- Alexander Klicznik-Hogan Lovells International LLP
- Felipe Zilly-Hogan Lovells International LLP
- Peter-Michael Weissesupporting-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Ole Dirkssupporting-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Eva Maria Thörnersupporting-Wildanger Kehrwald Graf von Schwerin & Partner mbB
Respondents- Edwards Lifesciences CorporationOperating co.
- Meril GmbHOperating co.
- Name withheld (GDPR)
Representatives- Boris Kreye-Bird & Bird LLP
- Elsa Tzschoppe-Bird & Bird LLP
- Bernhard Thumsupporting-Thum & Partner
- Bryce Matthewsonsupporting-Powell Gilbert (Europe) LLP
- Jonas Weickertsupporting-Thum & Partner
- Siddharth Kusumakarsupporting-Powell Gilbert (Europe) LLP
- Tessa Waldronsupporting-Powell Gilbert (Europe) LLP
- Division
- Munich LD
- Technology
- InstrumentsMedical technology
- Language
- English
- First decided
- Apr 9, 2025
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
| Judge Margot Kokke | Locked |
| Judge Tobias Pichlmaier | Locked |
| Judge Stefan Wilhelm | Locked |
At the UPC: Meril Group (60 cases)·Edwards Lifesciences Group (57 cases)
This dispute contains 18 other proceedings
UPC CoA 166/2025·UPC CoA 21/2025·UPC CoA 27/2025·UPC CFI 815/2024·UPC CoA 533/2024 and 13 more
7 other defendants litigating the same or a related patent
UPC CFI 202/2025·UPC CFI 674/2024·UPC CoA 530/2024·UPC CoA 532/2024·UPC CoA 457/2024 and 2 more
- 2025-04-09
Summary: The Munich Local Division judge-rapporteur issued a procedural order dealing with Meril's applications for cost reimbursement and confidentiality protection (R. 262A RoP) in the Edwards Lifesciences v. Meril proceedings. Following the judge-rapporteur's guidance, Meril withdrew the cost reimbursement applications. The order addressed the scope of confidentiality protection for legal fee invoices and related documents.
Show the legal issues (3)
- Confidentiality of legal fee invoices (R. 262A RoP)
- Withdrawal of cost reimbursement application (R. 262.2 RoP)
- Scope of confidentiality protection for attorney work product
| Document title | Date | Public |
|---|---|---|
| Case closed | 2025-10-29 | Not public |
| Outcome of the Order | 2025-04-22 | Not public |
| R 265 final | 2025-04-22 | Public |
| Headnote-and-Keywords | 2025-04-09 | Not public |
| R 265 final | 2025-04-09 | Public |
| Template-Order | 2025-04-09 | Not public |
| R 265 final | 2025-04-09 | Public |
| Outcome of the Order | 2025-04-09 | Not public |
| R 265 final | 2025-04-09 | Public |
| Further submission | 2025-03-27 | Not public |